Axsome Therapeutics, Inc. (AXSM) has a market capitalization of $9.42B and trades at $184.18. The 52-week range is 86.99-191.5.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -50, Earnings Per Share (EPS) of $-3.68, annual revenue of $638.5M.
The stock has a beta of 0.47, operates in the Healthcare sector.
